Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vinflunine plus best supportive care vs placebo plus best supportive care in previously treated malignant pleural mesothelioma
2008-003196-48Phase 2Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pleural mesothelioma comparing Oral vinflunine plus best supportive care with Placebo plus best supportive care (2 arms). Primary endpoint: Overall survival. Started Oct 2008; status: terminated.
02
Drugs
vinflunine
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2008-003196-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003196-48.